Project “Response to HIV”

In April 2015, Legebitra started to implement a 14-month multidisciplinary partner project “Response to HIV” in collaboration with Škuc Magnus, the DIH Association, the Institute of Microbiology and Immunology, the Clinic for Infectious Diseases and Fever and Association for the Health of LGBT People from Norway Helseutvalget for Bedre Homohelse , with the financial assistance of the Norwegian Funds and the Government Office for Development and European Cohesion Policy. The project has brought numerous novelties in the field of prevention and support. It has expanded the scope of testing for STIs (sexually transmitted infections); a crisis line for PEP (postexposure prophylaxis or protective antiretroviral therapy, which can prevent infection from HIV), and a specific Buddy program of individual support for people living with HIV, which also triggered a public debate on the introduction of PrEP (Pre-Exposure Prophylaxis is a therapy with the purpose of preventing infection with HIV before and after a period of sexual activity of an individual, which poses a high risk of infection with the virus. It is an antiviral medicine, which prevents infection with HIV, with the intention that an individual’s HIV status remains negative after consistently taking medications).